Susmed Inc
TSE:4263
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Susmed Inc
Revenue
Susmed Inc
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Susmed Inc
TSE:4263
|
Revenue
¥463m
|
CAGR 3-Years
13%
|
CAGR 5-Years
68%
|
CAGR 10-Years
N/A
|
|
|
M3 Inc
TSE:2413
|
Revenue
¥343.8B
|
CAGR 3-Years
14%
|
CAGR 5-Years
17%
|
CAGR 10-Years
19%
|
|
|
S
|
Software Service Inc
TSE:3733
|
Revenue
¥42.7B
|
CAGR 3-Years
14%
|
CAGR 5-Years
3%
|
CAGR 10-Years
10%
|
|
|
Medley Inc
TSE:4480
|
Revenue
¥36.8B
|
CAGR 3-Years
37%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
|
Medical Data Vision Co Ltd
TSE:3902
|
Revenue
¥6.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
10%
|
|
|
JMDC Inc
TSE:4483
|
Revenue
¥47.6B
|
CAGR 3-Years
23%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
Susmed Inc
Glance View
SUSMED, Inc. engages in the development of medical equipment and software systems. The company is headquartered in Chuo-Ku, Tokyo-To. The company went IPO on 2021-12-24. The firm operates through two business segments. The DTx Product segment is engaged in the development of application software products for treating diseases such as insomnia, breast cancer, chronic kidney diseases and others. The DTx Platform segment is engaged in the provision of general-purpose clinical trial systems and machine learning automatic analysis systems, as well as the provision of DTx development support services using systems.
See Also
What is Susmed Inc's Revenue?
Revenue
463m
JPY
Based on the financial report for Jun 30, 2025, Susmed Inc's Revenue amounts to 463m JPY.
What is Susmed Inc's Revenue growth rate?
Revenue CAGR 5Y
68%
Over the last year, the Revenue growth was 35%. The average annual Revenue growth rates for Susmed Inc have been 13% over the past three years , 68% over the past five years .
